COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,594 Articles (22,415 medRxiv, 8,179 bioRxiv)

Most recent first Previous |  Page 1095: Articles 10941-10950  | Next

Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study
Chen, Z., Zheng, W., Wu, Q., Chen, X., Peng, C., Tian, Y., Sun, R., Wang, M., Zhou, X., Zhao, Z., Zhong, G., Yan, X., Liu, N., Hao, F., Zhao, S., Zhuang, T., Yang, J., Azman, A., Yu, H.
10.1101/2021.10.25.21265504 — Posted: 2021-10-26
COVCOG 1: Factors predicting Cognitive Symptoms in Long COVID. A First Publication from the COVID and Cognition Study.
Guo, P., Benito Ballesteros, A., Yeung, S. P., Liu, R., Saha, A., Curtis, L., Kaser, M., Haggard, M. P., Cheke, L. G.
10.1101/2021.10.26.21265525 — Posted: 2021-10-26
Limited impact of Delta variants mutations in the effectiveness of neutralization conferred by natural infection or COVID-19 vaccines in a Latino population
Sariol, C. A., Serrano, C., Ortiz, E. J., Pantoja, P., Cruz, L., Arana, T., Atehortua, D., Pabon-Carrero, C., Espino, A. M.
10.1101/2021.10.25.21265422 — Posted: 2021-10-26
Optimising the balance of acute and intermediate care capacity for the complex discharge pathway: computer modelling study during COVID-19 recovery in England
Onen Dumlu, Z., Harper, A. L., Forte, P. G., Powell, A. L., Pitt, M., Vasilakis, C., Wood, R. M.
10.1101/2021.10.25.21265475 — Posted: 2021-10-26
Third doses of COVID-19 vaccines reduce infection and transmission of SARS-CoV-2 and could prevent future surges in some populations
Gardner, B. J., Kilpatrick, A. M.
10.1101/2021.10.25.21265500 — Posted: 2021-10-26
Epidemiological, virological and serological investigation into a SARS-CoV-2 outbreak (Alpha variant) in a primary school in Geneva, Switzerland: a prospective longitudinal study
Lorthe, E., Bellon, M., Michielin, G., Berthelot, J., Zaballa, M.-E., Pennacchio, F., Bekliz, M., Laubscher, F., Arefi, F., Perez-Saez, J., Azman, A. S., L'Huillier, A. G., Posfay-Barbe, K. M., Kaiser, L., Guessous, I., Maerkl, S. J., Eckerle, I., Stringhini, S.
10.1101/2021.10.26.21265509 — Posted: 2021-10-26
SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA- versus vector-based vaccination in the general Dutch population
van den Hoogen, L. L., Verheul, M. K., Vos, E. R., van Hagen, C. C., van Boven, M., Wong, D., Wijmenga-Monsuur, A. J., Smit, G., Kuijer, M., van Rooijen, D., Bogaard-van Maurik, M., Zutt, I., van Vliet, J., van der Klis, F. R., de Melker, H. E., van Binnendijk, R. S., den Hartog, G.
10.1101/2021.10.25.21265467 — Posted: 2021-10-26
Phylogenetic-based inference reveals distinct transmission dynamics of SARS-CoV-2 variant of concern Gamma and lineage P.2 in Brazil
Graf, T., Bello, G., Naveca, F. G., Gomes, M., Cardoso, V. L. O., Silva, A. F. d., Dezordi, F. Z., Santos, M. C. d., Santos, K. C. d. O., Batista, e. L. R., Magalhaes, A. L. a., Vinhal, F., Brazilian Ministry of Health COVID-19 Genomic Surveillance Network, , Miyajima, F., Faoro, H., Khouri, R., Wallau, G. L., Delatorre, E., Siqueira, M. M., Resende, P. C.
10.1101/2021.10.24.21265116 — Posted: 2021-10-26
Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada
Skowronski, D. M., Setayeshgar, S., Febriani, Y., Ouakki, M., Zou, M., Talbot, D., Prystajecky, N., Tyson, J. R., Gilca, R., Brousseau, N., Deceuninck, G., Galanis, E., Fjell, C. D., Sbihi, H., Fortin, E., Barkati, S., Sauvageau, C., Naus, M., Patrick, D. M., Henry, B., Hoang, L. M., De Wals, P., Garenc, C., Carignan, A., Drolet, M., Sadarangani, M., Brisson, M., Krajden, M., De Serres, G.
10.1101/2021.10.26.21265397 — Posted: 2021-10-26
Nucleocapsid antibody positivity as a marker of past SARS-CoV-2 infection in population serosurveillance studies: impact of variant, vaccination, and choice of assay cut-off
Whitaker, H. J., Gower, C., Otter, A. D., Simmons, R., Kirsebom, F., Letley, L., Quinot, C., Ireland, G., Linley, E., Ribeiro, S., Ladhani, S., Lopez-Bernal, J., Amirthalingam, G., Ramsay, M. E., Brown, K. E.
10.1101/2021.10.25.21264964 — Posted: 2021-10-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).